Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Juei-Seng Wu

Showing results (1-10 of 8) with videos related to

Pageof 1
Sort By:
Gastroenterology|March 26, 2023
A Pseudo-Gastric BubbleYi-Ning Lo, Juei-Seng Wu, Hsueh-Chien Chiang
Journal of Clinical Medicine|April 13, 2023
Serum Cardiotrophin-1 Concentration Is Negatively Associated with Controlled Attenuation Parameters in Subjects with Non-Alcoholic Fatty Liver DiseaseYi-Chun Liao, Juei-Seng Wu, Hsuan-Wen Chou, et al.
Life Sciences|July 6, 2022
Long-term consumption of the sugar substitute sorbitol alters gut microbiome and induces glucose intolerance in miceChung-Hao Li, Chung-Teng Wang, Ying-Ju Lin, et al.
Therapeutic Advances in Gastroenterology|April 10, 2026
Topical tranexamic acid and sucralfate prevent delayed bleeding after endoscopic sphincterotomy: a randomized controlled trial (with video)Hsueh-Chien Chiang, Jui-Wen Kang, Wei-Lun Chang, et al.
Journal of Gastrointestinal Oncology|May 18, 2023
Hepatic arterial infusion chemotherapy and immune checkpoint inhibitors, alone or in combination, in advanced hepatocellular carcinoma with macrovascular invasion: a single-centre experience in TaiwanJuei-Seng Wu, Tzu-Chun Hong, Hung-Tsung Wu, et al.
Pharmaceutics|November 11, 2022
Real-World Comparative Effectiveness of Nivolumab versus Pembrolizumab in Patients with Unresectable Hepatocellular CarcinomaHsin-Yu Kuo, Meng-Zhi Han, Chih-Hsiang Liao, et al.
Therapeutic Advances in Medical Oncology|January 13, 2025
Comparing immunotherapy effectiveness for unresectable hepatocellular carcinoma: infiltrative versus non-infiltrative types in real-world settingsChien-Ming Chiang, Kuan-Kai Huang, Chun-Te Lee, et al.
Cancers|February 11, 2023
Real-World Effectiveness of Sorafenib versus Lenvatinib Combined with PD-1 Inhibitors in Unresectable Hepatocellular CarcinomaHsueh-Chien Chiang, Yang-Cheng Lee, Ting-Tsung Chang, et al.
Pageof 1

Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
Gastroenterology|March 26, 2023
A Pseudo-Gastric BubbleYi-Ning Lo, Juei-Seng Wu, Hsueh-Chien Chiang
Journal of Clinical Medicine|April 13, 2023
Serum Cardiotrophin-1 Concentration Is Negatively Associated with Controlled Attenuation Parameters in Subjects with Non-Alcoholic Fatty Liver DiseaseYi-Chun Liao, Juei-Seng Wu, Hsuan-Wen Chou, et al.
Life Sciences|July 6, 2022
Long-term consumption of the sugar substitute sorbitol alters gut microbiome and induces glucose intolerance in miceChung-Hao Li, Chung-Teng Wang, Ying-Ju Lin, et al.
Therapeutic Advances in Gastroenterology|April 10, 2026
Topical tranexamic acid and sucralfate prevent delayed bleeding after endoscopic sphincterotomy: a randomized controlled trial (with video)Hsueh-Chien Chiang, Jui-Wen Kang, Wei-Lun Chang, et al.
Journal of Gastrointestinal Oncology|May 18, 2023
Hepatic arterial infusion chemotherapy and immune checkpoint inhibitors, alone or in combination, in advanced hepatocellular carcinoma with macrovascular invasion: a single-centre experience in TaiwanJuei-Seng Wu, Tzu-Chun Hong, Hung-Tsung Wu, et al.
Pharmaceutics|November 11, 2022
Real-World Comparative Effectiveness of Nivolumab versus Pembrolizumab in Patients with Unresectable Hepatocellular CarcinomaHsin-Yu Kuo, Meng-Zhi Han, Chih-Hsiang Liao, et al.
Therapeutic Advances in Medical Oncology|January 13, 2025
Comparing immunotherapy effectiveness for unresectable hepatocellular carcinoma: infiltrative versus non-infiltrative types in real-world settingsChien-Ming Chiang, Kuan-Kai Huang, Chun-Te Lee, et al.
Cancers|February 11, 2023
Real-World Effectiveness of Sorafenib versus Lenvatinib Combined with PD-1 Inhibitors in Unresectable Hepatocellular CarcinomaHsueh-Chien Chiang, Yang-Cheng Lee, Ting-Tsung Chang, et al.
Pageof 1